Onpattro (patisiran) is a medication used for treating nerve damage (polyneuropathy) due to hereditary transthyretin-mediated amyloidosis (hATTR). It's given as an injection into the veins every 3 weeks by a healthcare provider.
Polyneuropathy from hereditary transthyretin-mediated amyloidosis (hATTR)
Your liver makes a protein called transthyretin (TTR). In people with hereditary transthyretin-mediated amyloidosis (hATTR), the gene that makes TTR has a mutation that causes the protein to fold incorrectly into an unusual shape. This unusual shape causes TTR proteins to clump together in clusters called amyloid deposits or fibrils. These amyloid deposits travel throughout your body and can cause damage to your organs and nerves.
Onpattro (patisiran) is a type of molecule called an small interfering ribonucleic acid (siRNA). It's a piece of genetic material that attaches to the TTR gene and breaks it down. This lowers the amount of misshapened TTR proteins in your body, which lowers the amount of amyloid that builds up in your organs.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Needs to be given by a healthcare provider
Brand name only, which can be expensive
Requires you to take several medications 1 hour before the infusion to prevent infusion-related reactions
Mark your appointments to see your provider and receive Onpattro (patisiran) on your calendar. This makes sure your providers can properly monitor you and also helps you remember to receive your doses on time.
The Onpattro (patisiran) infusion takes about an hour and 20 minutes. After your infusion, your provider might want to monitor you for a while just in case you get any reactions to the medication. You can bring a book or something else to do with you to help pass the time.
It's possible to get infusion-related reactions during your Onpattro (patisiran) infusion. Examples of these reactions include flushing, back pain, nausea, stomach pain, shortness of breath, and headache. If you get any of these reactions during your infusion, tell your provider so they can slow or stop the infusion. They can also give you medications to treat your symptoms.
It's best to take a daily vitamin A supplement during Onpattro (patisiran) treatment. This is because
the medication can lower the vitamin A levels in your blood. Ask your provider how much vitamin A you should take every day.
Onpattro (patisiran) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Onpattro (patisiran) can cause infusion-related reactions while you receive the medication. Examples of these reactions include flushing, back pain, nausea, stomach pain, shortness of breath, and headache. If you develop any of these reactions during your infusion, tell your provider so they can slow or stop the Onpattro (patisiran) infusion. They might also give you medications to treat your symptoms. To prevent or lessen the severity of these reactions, your provider will give you a few medications to take at least 1 hour before your Onpattro (patisiran) infusion. These medications include a steroid (e.g., dexamethasone), acetaminophen (Tylenol), a histamine-2 antagonist (e.g., famotidine), and a histamine-1 antagonist (e.g., diphenhydramine (Benadryl)). Your provider might adjust the dose of these medications or switch to different ones, depending on how you respond to them.
Onpattro (patisiran) can lower your blood vitamin A levels. It's best to take a vitamin A supplement at the recommended daily dose while taking Onpattro (patisiran). If you're pregnant, speak to your provider about what dose of vitamin A is right for you, because having too much or too little vitamin A can affect the development of your baby. Don't take more than the maximum recommended daily dose to try and raise your vitamin A levels, because this can lead to side effects like nausea, dizziness, or headache. Contact your provider if you get night blindness, because this is an early symptom of very low vitamin A.
Weight of less than 220 lbs (100 kg): The typical dose is 0.3 mg/kg of body weight injected into the veins (intravenously or IV) once every 3 weeks.
Weight of 220 lbs or more: The typical dose is 30 mg IV once every 3 weeks.
Polyneuropathy from hereditary transthyretin-mediated amyloidosis (hATTR)
Polyneuropathy from hereditary transthyretin-mediated amyloidosis (hATTR)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.